Pharmaceutical Technology: News, Analysis & Industry Insights

News

Beyond GLP-1RA’s: Novel mechanisms and combos to shape future of obesity market

Emerging mechanisms and combinatorial approaches are redefining the obesity space as the outcome focus shifts away from weight loss alone.

Annabel Kartal Allen

News

FDA puts commissioner’s priority voucher framework on ice

Robert Barrie

News

Eli Lilly beats Novo to oral China GLP-1RA market on NMPA approval

Annabel Kartal Allen

News

Takeda begins US distribution of narcolepsy type 1 drug Orzeyful

News

Neurosterix pockets $105m to advance neuropsychiatry pipeline

News

BMS sets unified research and development structure for 2027

News

Blackstone backs Pfizer’s obesity ambitions with $1.5bn fund

News

FDA and EMA waive paediatric studies for Shanton’s gout candidate

Analysis

PremiumAnalyst Comment

AHA26: Boehringer’s survodutide establishes CV safety in SYNCHRONIZE-CVOT

GlobalData Healthcare

PremiumAnalyst Comment

AHA26: Semaglutide’s real-world CV benefits highlight importance of persistence

GlobalData Healthcare

PremiumFeatures

BIO Europe: Financing, AI and geopolitics shape biotech discourse

Annabel Kartal Allen

Features

Podcast: Longevity, China, and AI the talk of the town at BIO Europe 2026

Annabel Kartal Allen

Themes

News

Anthropic plots IPO amid ongoing foray into drug development

Anthropic hopes Powerful AI will “match or exceed the cognitive capabilities of top human experts across scientific disciplines”.

More themes

Partner Content

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

News

Australia starts investigation into OpenAI Medicare breach

Partner Content

How DFE Pharma supports confident continuous manufacturing decisions

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Peripheral Arterial Disease (PAD): Market View, Current and Future Competitive Landscape

$3495.00

Systemic Sclerosis in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

$17995.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

FDA puts commissioner’s priority voucher framework on ice

Eli Lilly beats Novo to oral China GLP-1RA market on NMPA approval

Takeda begins US distribution of narcolepsy type 1 drug Orzeyful

Neurosterix pockets $105m to advance neuropsychiatry pipeline

BMS sets unified research and development structure for 2027

Blackstone backs Pfizer’s obesity ambitions with $1.5bn fund

FDA and EMA waive paediatric studies for Shanton’s gout candidate

AHA26: Boehringer’s survodutide establishes CV safety in SYNCHRONIZE-CVOT

AHA26: Semaglutide’s real-world CV benefits highlight importance of persistence

BIO Europe: Financing, AI and geopolitics shape biotech discourse

Podcast: Longevity, China, and AI the talk of the town at BIO Europe 2026

Anthropic plots IPO amid ongoing foray into drug development

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Peripheral Arterial Disease (PAD): Market View, Current and Future Competitive Landscape

Systemic Sclerosis in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

IDWeek 2026: Conference Highlights

CRO Activity and Intel Report Q3 2026

Acne Vulgaris: Market View, Current and Future Competitive Landscape

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Peripheral Arterial Disease (PAD): Market View, Current and Future Competitive Landscape

Systemic Sclerosis in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

IDWeek 2026: Conference Highlights

CRO Activity and Intel Report Q3 2026

Acne Vulgaris: Market View, Current and Future Competitive Landscape

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing